...A. Highlights: Organic sales growth was 10% with double-digit growth from MedSurg and Neurotechnology businesses, led by endoscopy, medical and neuro cranial. 1. Hip and knee businesses delivered double-digit growth, reflecting continued recovery of elective procedures and worldwide Mako momentum. a. b. Continued strong international performance with double-digit organic growth led by Europe, Canada and emerging markets, despite negative growth in China. 2. Adjusted EPS of $2.12, driven by strong sales performance, partially offsetting negative foreign currency and inflationary pressures. Expects these pressures to continue, but at more moderate level for remainder of 2022. a. 3. Pleased with strong sales growth, which would have been even higher if not for material shortages, mostly affecting medical and instruments. 4. Taking actions to deal with cost headwinds, including inflationary challenges. As noted in 2Q, given higher input costs, took series of pricing actions across portfolio....
